...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith A Loser Too
2
Jun 16, 2020 01:38PM

I guess the problem I have whether the deal is good, fair, bad, etc is that I had big expectations that we would see something far more positive like some sort of deal not just another second rate financing negotiated from a position of weakness. It strikes me again that Don has nothing to sell or he doesn't know how to sell what he has.

That being said I'm glad the ship is floating and slowly inching forward I hope.

I'm also glad we are getting an update (as last minute as it seems).

Toinv

1
Jun 16, 2020 03:33PM
Share
New Message
Please login to post a reply